OA07721A - Malaria associated antigen and preparing process thereof. - Google Patents

Malaria associated antigen and preparing process thereof.

Info

Publication number
OA07721A
OA07721A OA58315A OA58315A OA07721A OA 07721 A OA07721 A OA 07721A OA 58315 A OA58315 A OA 58315A OA 58315 A OA58315 A OA 58315A OA 07721 A OA07721 A OA 07721A
Authority
OA
OAPI
Prior art keywords
associated antigen
preparing process
malaria associated
malaria
preparing
Prior art date
Application number
OA58315A
Other languages
English (en)
Inventor
Shoshiro Asakura
Masakazu Adachi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of OA07721A publication Critical patent/OA07721A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4647—Protozoa antigens
    • A61K39/464714—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
OA58315A 1983-06-10 1984-06-08 Malaria associated antigen and preparing process thereof. OA07721A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58103901A JPS59227827A (ja) 1983-06-10 1983-06-10 マラリア原虫由来糖鎖関連抗原及びその製造法

Publications (1)

Publication Number Publication Date
OA07721A true OA07721A (en) 1985-08-30

Family

ID=14366322

Family Applications (1)

Application Number Title Priority Date Filing Date
OA58315A OA07721A (en) 1983-06-10 1984-06-08 Malaria associated antigen and preparing process thereof.

Country Status (13)

Country Link
US (1) US4643896A (es)
EP (1) EP0129173A3 (es)
JP (1) JPS59227827A (es)
KR (1) KR910002521B1 (es)
AU (1) AU565489B2 (es)
CA (1) CA1231051A (es)
DK (1) DK282384A (es)
ES (1) ES8600937A1 (es)
IL (1) IL71953A (es)
IN (1) IN160524B (es)
OA (1) OA07721A (es)
PH (1) PH21427A (es)
ZA (1) ZA844263B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767622A (en) * 1983-08-19 1988-08-30 University Of Illinois Method and materials for development of immunological responses protective against malarial infection
WO1989001785A1 (en) * 1987-09-04 1989-03-09 Georgetown University Monoclonal antibodies to a plasmodium falciparum protein
IT1233419B (it) * 1987-12-11 1992-03-31 Eniricerche Spa Peptidi sintetici immunologicamente attivi utili per la preparazione di un vaccino antimalaria
US5264342A (en) * 1988-05-10 1993-11-23 Verigen, Inc. Method for determining the sensitivity and/or specificity of an assay system for detecting antibodies
FR2665909B1 (fr) * 1990-08-14 1992-11-13 Pasteur Institut Polypeptides de surface de globules rouges infectes par p. falciparum et compositions immunogenes les contenant.
KR930701975A (ko) * 1990-11-09 1993-09-08 제랄드 에프. 버크 항체 탐지를 위한 검사 시스템의 민감성 그리고/혹은 특이성을 결정하는 방법
CN1176945C (zh) * 2001-02-01 2004-11-24 中国人民解放军第二军医大学 疟原虫融合抗原及其制法和用途
US8758286B2 (en) * 2009-12-01 2014-06-24 Exthera Medical Corporation Method for removing cytokines from blood with surface immobilized polysaccharides
DE15782250T1 (de) 2014-04-24 2017-08-10 Exthera Medical Corporation Verfahren zur Entfernung von Bakterien aus Blut unter Verwendung einer hohen Durchflussrate
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
JP2022534191A (ja) 2019-05-16 2022-07-28 エクスセラ メディカル コーポレイション 内皮糖衣構造を調節するための方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2469457A (en) * 1945-09-17 1949-05-10 Univ Tennessee Res Corp Process for producing an antigen for use in the diagnosis of malaria and product thereof
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
IL65496A (en) * 1981-04-15 1985-10-31 Wellcome Found Protozoal antigen,its preparation and vaccine containing it
DE3280028D1 (en) * 1981-05-21 1989-12-28 Wellcome Found Protozoal antigen
GB2099300B (en) * 1981-05-21 1985-02-27 Wellcome Found Antigens from parasites of the genus plasmodium
US4416872A (en) * 1982-03-17 1983-11-22 The United States Of America As Represented By The Secretary Of The Army Treatment of malaria with liposomes containing 8-aminoquinoline derivatives and glycoconjugates

Also Published As

Publication number Publication date
DK282384A (da) 1984-12-11
AU565489B2 (en) 1987-09-17
IL71953A (en) 1987-10-30
US4643896A (en) 1987-02-17
PH21427A (en) 1987-10-15
JPS59227827A (ja) 1984-12-21
KR850000247A (ko) 1985-02-26
EP0129173A3 (en) 1985-07-24
CA1231051A (en) 1988-01-05
ZA844263B (en) 1985-01-30
IL71953A0 (en) 1984-09-30
ES533250A0 (es) 1985-10-16
DK282384D0 (da) 1984-06-08
IN160524B (es) 1987-07-18
KR910002521B1 (ko) 1991-04-23
EP0129173A2 (en) 1984-12-27
ES8600937A1 (es) 1985-10-16
AU2894884A (en) 1984-12-13

Similar Documents

Publication Publication Date Title
IL73159A0 (en) Carboxyalkenamidocephalosporines,process for the preparation thereof and methods for the use thereof
IL68749A (en) Modified antigens,their preparation and vaccines containing them
IL70727A0 (en) Coupled h.influenzae type b vaccine
IL61904A0 (en) Novel synthetic vaccine and process for producing same
EP0171434A4 (en) CROSSLINKING AGENTS AND THEIR PRODUCTION METHOD.
KR960008863B1 (en) Rom and process for producing the same
DE3473767D1 (en) Five-component copolyester, process for preparation thereof, and shaped articles thereof
JPS57197222A (en) Malaria antibody
EP0245993A3 (en) Monoclonal antibodies against c5a and des-arg74-c5a, their production and use
AU561529B2 (en) Plasmodium antigen
YU135784A (en) Process for making dihydroimidazopyrolopyridine and hinoline, tieno-dihydrotieno-furo-i dihydrofuroimidazopyrolopyridine
IL70968A0 (en) Urea-linked immunogens,their preparation and antibodies thereto
IL67808A0 (en) Plant-promoting preparations,process for the manufacture thereof and methods for the use thereof
OA07721A (en) Malaria associated antigen and preparing process thereof.
EP0131627A4 (en) SPECIFIC ANTIGENS OF THE CEA FAMILY (CARCINO-EMBRYONIC ANTIGEN), SPECIFIC ANTIBODIES OF THESE ANTIGENS AND THEIR METHODS OF USE.
YU44113B (en) Process for preparing glyoxale, alkylglyoxales and their acethales
DE3463041D1 (en) Tributylphenolether-glycidyl-sulphonates, process for their preparation and their use
GB2145419B (en) Vaccines
EP0134246A4 (en) PROSTACYCLINE AND THEIR PRODUCTION PROCESS.
GB2146325B (en) 16-fluoro-16,17-didehydro prostanoids and process for their preparation
GB2143526B (en) Preparing 3,3,3-trifluoro-2-trifluoromet
IL85645A0 (en) General cancer-associated scm-recognition factor,preparation and method
EG16749A (en) Malaria associated antigen and preparing process thereof
DE3266870D1 (en) Dicyandiamide-formaldehyde condensates and process for preparing the same
IL71560A0 (en) Process for preparing substituted 2,3-dihydrobenzofurans and means adapted therefor